The article looks at the key trends arising out of the pandemic and the ‘new normal’ and assess what these may mean for life sciences arbitration in the coming months and years. The authors address the fallout of the vaccine rollout, global vaccine inequality, a rise in M&A, and supply chain disruption.
To read the article, click here.
ABOUT LEILAH BRUTON
Leilah is a partner in our London office. She has extensive experience representing corporations on the resolution of complex disputes involving investment treaties and contractual relationships, with a particular focus on disputes in the oil & gas, mining, and telecoms sectors.
Leilah has been named a Who’s Who Legal: Future Leader for 2018-2022, in which peers and clients described her as “one of the most efficient practitioners” and as having “outstanding leadership skills”. Leilah has also been recognised as a Rising Star for both international arbitration and public international law in The Legal 500 UK 2022, and a Rising Star in The Legal 500’s International Arbitration Powerlist 2019 for the UK.
ABOUT RICHARD TRINICK
Richard, a senior associate in the London office, has acted on many large and complex arbitrations across a variety of sectors and regions, with a particular focus on energy, M&A, telecommunications, and technology disputes.« Back